Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade.
Nat Commun. 2021 Jun 7;12(1):3414. doi: 10.1038/s41467-021-23731-7.
Nat Commun. 2021.
PMID: 34099731
Free PMC article.